(IN BRIEF) Laborie, a subsidiary of Patricia Industries, is set to acquire the remaining 91 percent of Urotronic, a US medical technology company known for its OptilumeTM device for treating benign prostatic hyperplasia (BPH). In 2020, Laborie entered a strategic … Read the full press release →
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Science, Sweden, Technology
Tagged acquisition, benign prostatic hyperplasia (BPH), investment, Investor AB, Johan Forssell, Laborie, medical technology, Michael Frazzette, OptilumeTM BPH, partnership, Patricia Industries, Urotronic, wellness